News + Insights

All
Blog + Whitepapers
Webinars
News
sanofi dren bio - 1
Sanofi Commits up to $1.9B for Dren Bio’s Bispecific Antibody for Autoimmune Disease
In the latest investment in the immunology space, Sanofi has agreed to a $600 million upfront payment to...
Read More
HPE header image
Key Takeaways from HPE Miami 2025: A Cautious Yet Evolving Private Equity Landscape
The Revelation Partners team was in Miami March 5-6 for the HPE Miami Conference. The conference, which...
Read More
AI Header image
Riding the AI Wave in Medical Imaging: Navigating Adoption Hurdles, Disruption, and Scaling Success
In the current AI landscape dominated by headlines about Large Language Models (LLMs) like GPT-4 and...
Read More
VitalConnect Image
VitalConnect, Inc. Secures $100 Million in Financing
VitalConnect®, Inc., a leader in biosensor technology, specializing in ambulatory cardiac monitoring,...
Read More
508_350
Crown Laboratories Completes Acquisition of Revance Therapeutics
Crown Laboratories, Inc. (“Crown”), a Hildred Capital portfolio company and privately held,...
Read More
RP Header image (4)
Discounts and the Impact of Shareholder Rights in Private Market Secondaries
Revelation Partners is commonly asked what our typical discount is. There is no “typical” discount, nor...
Read More

Flexible capital for the healthcare ecosystem

Disclaimer

The information contained herein is for informational and educational purposes only, does not constitute an offer to sell or the solicitation of an offer to purchase any security, is not presented with a view to providing investment advice with respect to any security, or making any claim as to the past, current or future performance thereof, and Revelation expressly disclaims the use of this information for such purposes. Each recipient should consult its own advisers as to legal, business, tax and other related matters concerning any investment. Statements contained herein are based on current opinions, views and beliefs of Revelation as of the date of the post. Neither Revelation nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the information contained herein and nothing contained herein should be relied upon as a promise or representation as to past or future performance. Revelation does not have any obligation to update any information included herein. Recipients agree that none of Revelation or its affiliates or its or their respective partners, members, employees, officers, directors, agents, or representatives shall have any liability for any misstatement or omission of fact or any opinion expressed herein.